For the year ending 2025-12-31, IOVA has $913,170K in assets. $214,587K in debts. $163,078K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 163,078 | |||
| Trade accounts receivable | 82,448 | |||
| Short-term investments | 133,902 | |||
| Inventory | 51,678 | |||
| Prepaid expenses and other assets | 11,583 | |||
| Total current assets | 442,689 | |||
| Property and equipment, net | 131,112 | |||
| Intangible assets, net | 279,324 | |||
| Operating lease right-of-use assets | 45,899 | |||
| Restricted cash | 5,980 | |||
| Long-term assets | 8,166 | |||
| Total assets | 913,170 | |||
| Accounts payable | 22,159 | |||
| Accrued expenses and other liabilities | 111,156 | |||
| Note payable - current | 1,000 | |||
| Operating lease liabilities | 4,043 | |||
| Total current liabilities | 138,358 | |||
| Operating lease liabilities - non-current | 44,401 | |||
| Deferred tax liabilities | 31,828 | |||
| Total non-current liabilities | 76,229 | |||
| Total liabilities | 214,587 | |||
| Preferred stock, value-Series BPreferred Stock | 2 | |||
| Common stock, 0.000041666 par value 500,000,000 shares authorized, 411,938,061 and 305,252,194 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 17 | |||
| Accumulated other comprehensive income (loss) | 16,440 | |||
| Additional paid-in capital | 3,457,654 | |||
| Accumulated deficit | -2,775,530 | |||
| Total stockholders' equity | 698,583 | |||
| Total liabilities and stockholders' equity | 913,170 | |||
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)